SYBODY
LIVE

Serial Number

79279166

Owner

Linkster Therapeutics AG

Attorney

Julie Reitz

Filing Date

Dec 20, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SYBODY Trademark

Serial Number: 79279166 • Registration: 6571257

SYBODY is a trademark filed by Linkster Therapeutics AG on December 20, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Linkster Therapeutics AG (3 trademarks)

Stampfenbachstrasse 142

Entity Type: 25

Iwan Zimmermann (2 trademarks)

Gloriastrasse 27

Entity Type: 01

Roger Dawson (2 trademarks)

Stampfenbachstrasse 142

Entity Type: 01

Pascal Egloff (2 trademarks)

Glärnischstrasse 5

Entity Type: 01

Trademark Details

Filing Date

December 20, 2019

Registration Date

November 30, 2021

Published for Opposition

September 14, 2021

Goods & Services

Pharmaceutical preparations, namely, novel therapeutic antibodies; medical and veterinary preparations in the nature of vaccines; bacterial preparations for medical and veterinary use; medical preparations for the treatment of gout; veterinary preparations for treatment of intestinal bacteria; hygienic products for medical use, namely, disinfectants for medical hygienic purposes; all of the aforementioned exclude vitamin supplements

Diagnostic preparations for scientific and research purposes; diagnostic reagents for scientific and research purposes; diagnostic preparations for scientific use, namely, molecules, antibodies, nanobodies, peptides, target molecules; chemical and biochemical substances for in vitro and in vivo scientific use; chemical materials, namely, chemical agents for chelating and sequestering, rheology modifiers for use in the field of coating materials and chemical preparations, namely, chemical preparations for scientific purposes, industrial chemicals and natural elements, namely, diamond molecules for use in pharmaceuticals

Scientific research services for identification and quantification of molecules, in particular polypeptides, from a series of molecules; scientific research services using a series of bar codes for identifying molecules selected by mass spectrometry; scientific analyses in the field of molecular biology; consultancy in the field of technological research in the area of diagnostic preparations; scientific advice relating to research and development in the field of therapeutic procedures; consulting services in the field of pharmaceutical research; consulting services for gene therapy research; provision of scientific information and data relating to medical and veterinary product research and development; biochemical and biotechnological research and development; research, testing and computer-aided scientific analysis in the field of pharmaceuticals and biochemicals; scientific research in the field of proteins, antibodies, microorganisms and cells; computer software development

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 5, 2022 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Jun 10, 2022 NREP
FINAL DISPOSITION NOTICE SENT TO IB
May 19, 2022 FICS
FINAL DISPOSITION PROCESSED
May 18, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 30, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 14, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 25, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 25, 2021 OP2R
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 7, 2021 OPNX
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 5, 2021 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 21, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 21, 2021 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 9, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 9, 2021 GNFR
FINAL REFUSAL WRITTEN
Feb 9, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2021 CRFA
ASSIGNED TO LIE
Jan 7, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2020 TROA
CHANGE OF OWNER RECEIVED FROM IB
Aug 13, 2020 CHLD
REFUSAL PROCESSED BY IB
Apr 24, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 8, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 8, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 21, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 20, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 28, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2020 REPR